Your browser doesn't support javascript.
loading
Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial.
Bekker, Linda-Gail; Roux, Surita; Sebastien, Elaine; Yola, Ntando; Amico, K Rivet; Hughes, James P; Marzinke, Mark A; Hendrix, Craig W; Anderson, Peter L; Elharrar, Vanessa; Stirratt, Michael; Rooney, James F; Piwowar-Manning, Estelle; Eshleman, Susan H; McKinstry, Laura; Li, Maoji; Dye, Bonnie J; Grant, Robert M.
Afiliación
  • Bekker LG; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa. Electronic address: Linda-Gail.Bekker@hiv-research.org.za.
  • Roux S; Synexus Clinical Research SA, Somerset West, Cape Town, South Africa.
  • Sebastien E; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
  • Yola N; The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
  • Amico KR; School of Public Health, University of Michigan, Ann Arbor, MI, USA.
  • Hughes JP; Department of Biostatistics, University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Marzinke MA; Department of Medicine, Johns Hopkins University, Baltimore, MD, USA; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Hendrix CW; Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Anderson PL; Department of Pharmaceutical Sciences, University of Colorado, Aurora, CO, USA.
  • Elharrar V; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD USA.
  • Stirratt M; Division of AIDS Research, National Institute of Mental Health, National Institutes of Health, Bethesda, MD USA.
  • Rooney JF; Gilead Sciences, Foster City, CA, USA.
  • Piwowar-Manning E; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Eshleman SH; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • McKinstry L; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Li M; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Dye BJ; FHI 360, Durham, NC, USA.
  • Grant RM; Gladstone Institutes, University of California, and San Francisco AIDS Foundation, San Francisco, CA, USA.
Lancet HIV ; 5(2): e68-e78, 2018 02.
Article en En | MEDLINE | ID: mdl-28986029
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Profilaxis Pre-Exposición / Tenofovir / Emtricitabina Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans País/Región como asunto: Africa Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Profilaxis Pre-Exposición / Tenofovir / Emtricitabina Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans País/Región como asunto: Africa Idioma: En Año: 2018 Tipo del documento: Article